Derek Archila's Stock Ratings

Wells Fargo Analyst

Derek Archila is an analyst at Wells Fargo. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/18/2025

Overall Average Return

5.41%

Smart Score

59.5%

Overall Average Return Percentile

52nd

Number of Ratings

213
Buy NowGet Alert
03/12/2025ARVNBuy Now
Arvinas
$8.36210.92%
Derek Archila59%
$60 → $26MaintainsOverweightGet Alert
03/12/2025QTTBBuy Now
Q32 Bio
$2.22575.68%
Derek Archila59%
$16 → $15MaintainsEqual-WeightGet Alert
02/28/2025ARGXBuy Now
argenx
$610.0021.48%
Derek Archila59%
$723 → $741MaintainsOverweightGet Alert
02/24/2025EXELBuy Now
Exelixis
$36.36-0.99%
Derek Archila59%
$36 → $36DowngradeOverweight → Equal-WeightGet Alert
02/18/2025SEPNBuy Now
Septerna
$6.00133.33%
Derek Archila59%
$43 → $14DowngradeOverweight → Equal-WeightGet Alert
02/13/2025ANABBuy Now
AnaptysBio
$16.14215.99%
Derek Archila59%
$40 → $51MaintainsOverweightGet Alert
01/30/2025ZNTLBuy Now
Zentalis Pharma
$1.79235.2%
Derek Archila59%
$8 → $6MaintainsEqual-WeightGet Alert
12/19/2024ARGXBuy Now
argenx
$610.0018.52%
Derek Archila59%
$639 → $723MaintainsOverweightGet Alert
12/19/2024ZYMEBuy Now
Zymeworks
$12.3413.45%
Derek Archila59%
$12 → $14MaintainsEqual-WeightGet Alert
12/19/2024KZRBuy Now
Kezar Life Sciences
$5.7656.25%
Derek Archila59%
$11 → $9MaintainsEqual-WeightGet Alert
12/19/2024INCYBuy Now
Incyte
$60.0016.67%
Derek Archila59%
$68 → $70MaintainsEqual-WeightGet Alert
12/19/2024IMVTBuy Now
Immunovant
$19.99125.11%
Derek Archila59%
$47 → $45MaintainsOverweightGet Alert
12/19/2024CABABuy Now
Cabaletta Bio
$1.69255.03%
Derek Archila59%
$12 → $6DowngradeOverweight → Equal-WeightGet Alert
12/19/2024CCCCBuy Now
C4 Therapeutics
$2.10471.43%
Derek Archila59%
$8 → $12UpgradeEqual-Weight → OverweightGet Alert
12/19/2024GLUEBuy Now
Monte Rosa Therapeutics
$6.6764.92%
Derek Archila59%
$14 → $11DowngradeOverweight → Equal-WeightGet Alert
12/19/2024VRDNBuy Now
Viridian Therapeutics
$15.1478.34%
Derek Archila59%
→ $27DowngradeOverweight → Equal-WeightGet Alert
12/12/2024ANABBuy Now
AnaptysBio
$16.14147.83%
Derek Archila59%
$56 → $40MaintainsOverweightGet Alert
12/11/2024SLRNBuy Now
Acelyrin
$2.82360.99%
Derek Archila59%
$15 → $13MaintainsOverweightGet Alert
12/11/2024QTTBBuy Now
Q32 Bio
$2.22620.72%
Derek Archila59%
$95 → $16DowngradeOverweight → Equal-WeightGet Alert
12/02/2024KYMRBuy Now
Kymera Therapeutics
$34.0367.5%
Derek Archila59%
$38 → $57UpgradeEqual-Weight → OverweightGet Alert
11/19/2024SEPNBuy Now
Septerna
$6.00616.67%
Derek Archila59%
→ $43Initiates → OverweightGet Alert
11/15/2024CABABuy Now
Cabaletta Bio
$1.69610.06%
Derek Archila59%
$20 → $12MaintainsOverweightGet Alert
11/15/2024KYTXBuy Now
Kyverna Therapeutics
$2.43887.61%
Derek Archila59%
$44 → $24MaintainsOverweightGet Alert
11/14/2024KZRBuy Now
Kezar Life Sciences
$5.7690.97%
Derek Archila59%
$20 → $11MaintainsEqual-WeightGet Alert
11/06/2024APLSBuy Now
Apellis Pharmaceuticals
$24.4122.9%
Derek Archila59%
$43 → $30MaintainsEqual-WeightGet Alert
11/01/2024ARGXBuy Now
argenx
$610.004.75%
Derek Archila59%
$547 → $639MaintainsOverweightGet Alert
11/01/2024ZYMEBuy Now
Zymeworks
$12.34-2.76%
Derek Archila59%
$12 → $12DowngradeOverweight → Equal-WeightGet Alert
10/31/2024BPMCBuy Now
Blueprint Medicines
$89.5968.55%
Derek Archila59%
$153 → $151MaintainsOverweightGet Alert
10/30/2024INCYBuy Now
Incyte
$60.0013.33%
Derek Archila59%
$62 → $68MaintainsEqual-WeightGet Alert
10/30/2024EXELBuy Now
Exelixis
$36.36-0.99%
Derek Archila59%
$32 → $36MaintainsOverweightGet Alert
10/16/2024SLRNBuy Now
Acelyrin
$2.82431.91%
Derek Archila59%
$13 → $15MaintainsOverweightGet Alert
10/10/2024INCYBuy Now
Incyte
$60.003.33%
Derek Archila59%
$63 → $62MaintainsEqual-WeightGet Alert
10/04/2024ATYRBuy Now
aTyr Pharma
$3.92333.67%
Derek Archila59%
→ $17Initiates → OverweightGet Alert
09/24/2024APLSBuy Now
Apellis Pharmaceuticals
$24.4176.16%
Derek Archila59%
$47 → $43MaintainsEqual-WeightGet Alert
09/17/2024ASNDBuy Now
Ascendis Pharma
$164.6575.52%
Derek Archila59%
$264 → $289MaintainsOverweightGet Alert
09/04/2024ASNDBuy Now
Ascendis Pharma
$164.6560.34%
Derek Archila59%
$277 → $264MaintainsOverweightGet Alert
08/12/2024VTYXBuy Now
Ventyx Biosciences
$1.37702.92%
Derek Archila59%
$16 → $11MaintainsOverweightGet Alert
08/12/2024CLDXBuy Now
Celldex Therapeutics
$19.8986.02%
Derek Archila59%
$35 → $37MaintainsEqual-WeightGet Alert
08/12/2024KYMRBuy Now
Kymera Therapeutics
$34.0311.67%
Derek Archila59%
$30 → $38MaintainsEqual-WeightGet Alert
08/12/2024CABABuy Now
Cabaletta Bio
$1.691083.43%
Derek Archila59%
$35 → $20MaintainsOverweightGet Alert
08/12/2024GLUEBuy Now
Monte Rosa Therapeutics
$6.67154.87%
Derek Archila59%
$18 → $17MaintainsOverweightGet Alert
07/26/2024ARGXBuy Now
argenx
$610.00-10.33%
Derek Archila59%
$543 → $547MaintainsOverweightGet Alert
07/08/2024SLRNBuy Now
Acelyrin
$2.82360.99%
Derek Archila59%
$13 → $13UpgradeEqual-Weight → OverweightGet Alert
06/24/2024ARGXBuy Now
argenx
$610.00-11.15%
Derek Archila59%
$478 → $542MaintainsOverweightGet Alert
06/18/2024ZNTLBuy Now
Zentalis Pharma
$1.79402.79%
Derek Archila59%
$29 → $9DowngradeOverweight → Equal-WeightGet Alert
05/23/2024APLSBuy Now
Apellis Pharmaceuticals
$24.4196.64%
Derek Archila59%
$57 → $48MaintainsEqual-WeightGet Alert
05/15/2024ANNXBuy Now
Annexon
$2.62281.68%
Derek Archila59%
$12 → $10MaintainsOverweightGet Alert
05/09/2024CCCCBuy Now
C4 Therapeutics
$2.10280.95%
Derek Archila59%
$7 → $8MaintainsEqual-WeightGet Alert
05/09/2024ARVNBuy Now
Arvinas
$8.36617.51%
Derek Archila59%
$63 → $60MaintainsOverweightGet Alert
05/03/2024ZYMEBuy Now
Zymeworks
$12.34-2.76%
Derek Archila59%
$14 → $12MaintainsOverweightGet Alert
05/03/2024ASNDBuy Now
Ascendis Pharma
$164.6559.13%
Derek Archila59%
$260 → $262MaintainsOverweightGet Alert
04/18/2024RYTMBuy Now
Rhythm Pharmaceuticals
$52.29-0.55%
Derek Archila59%
$53 → $52MaintainsOverweightGet Alert
04/11/2024ANABBuy Now
AnaptysBio
$16.14246.96%
Derek Archila59%
→ $56Initiates → OverweightGet Alert
04/01/2024ANNXBuy Now
Annexon
$2.62358.02%
Derek Archila59%
$12 → $12MaintainsOverweightGet Alert
03/27/2024ANNXBuy Now
Annexon
$2.62358.02%
Derek Archila59%
$11 → $12MaintainsOverweightGet Alert
03/22/2024CABABuy Now
Cabaletta Bio
$1.691971.01%
Derek Archila59%
$34 → $35MaintainsOverweightGet Alert
03/21/2024SLRNBuy Now
Acelyrin
$2.82360.99%
Derek Archila59%
$11 → $13MaintainsEqual-WeightGet Alert
03/15/2024ASNDBuy Now
Ascendis Pharma
$164.6557.91%
Derek Archila59%
$196 → $260MaintainsOverweightGet Alert
03/14/2024MORBuy Now
MorphoSys
——
Derek Archila59%
$17 → $18.25DowngradeOverweight → Equal-WeightGet Alert
03/12/2024ZYMEBuy Now
Zymeworks
$12.3413.45%
Derek Archila59%
$12 → $14MaintainsOverweightGet Alert
03/12/2024VTYXBuy Now
Ventyx Biosciences
$1.371067.88%
Derek Archila59%
$7 → $16UpgradeEqual-Weight → OverweightGet Alert
02/20/2024ARGXBuy Now
argenx
$610.00-21.64%
Derek Archila59%
$472 → $478MaintainsOverweightGet Alert
02/16/2024NRIXBuy Now
Nurix Therapeutics
$13.6646.41%
Derek Archila59%
$23 → $20MaintainsOverweightGet Alert
02/05/2024MORBuy Now
MorphoSys
——
Derek Archila59%
→ $17ReiteratesOverweight → OverweightGet Alert
12/21/2023ARGXBuy Now
argenx
$610.00-22.95%
Derek Archila59%
$585 → $470MaintainsOverweightGet Alert
12/19/2023KYMRBuy Now
Kymera Therapeutics
$34.03-23.6%
Derek Archila59%
→ $26DowngradeOverweight → Equal-WeightGet Alert
12/19/2023VTYXBuy Now
Ventyx Biosciences
$1.37118.98%
Derek Archila59%
$8 → $3MaintainsEqual-WeightGet Alert
12/19/2023RYTMBuy Now
Rhythm Pharmaceuticals
$52.291.36%
Derek Archila59%
$48 → $53MaintainsOverweightGet Alert
12/19/2023BPMCBuy Now
Blueprint Medicines
$89.5928.36%
Derek Archila59%
$86 → $115MaintainsOverweightGet Alert
12/19/2023ASNDBuy Now
Ascendis Pharma
$164.65-9.51%
Derek Archila59%
$137 → $149MaintainsOverweightGet Alert
12/19/2023ARVNBuy Now
Arvinas
$8.36653.39%
Derek Archila59%
→ $63UpgradeEqual-Weight → OverweightGet Alert
12/15/2023MORBuy Now
MorphoSys
——
Derek Archila59%
$10 → $17MaintainsOverweightGet Alert
12/14/2023APLSBuy Now
Apellis Pharmaceuticals
$24.41121.22%
Derek Archila59%
$67 → $54DowngradeOverweight → Equal-WeightGet Alert
12/13/2023SLRNBuy Now
Acelyrin
$2.82290.07%
Derek Archila59%
→ $11Initiates → Equal-WeightGet Alert
11/14/2023KZRBuy Now
Kezar Life Sciences
$5.76-65.28%
Derek Archila59%
$40 → $20MaintainsEqual-WeightGet Alert
11/10/2023CLDXBuy Now
Celldex Therapeutics
$19.8935.75%
Derek Archila59%
→ $27UpgradeUnderweight → Equal-WeightGet Alert
11/08/2023RYTMBuy Now
Rhythm Pharmaceuticals
$52.29-23.5%
Derek Archila59%
$38 → $40MaintainsOverweightGet Alert
09/27/2023IMVTBuy Now
Immunovant
$19.99140.12%
Derek Archila59%
$33 → $48MaintainsOverweightGet Alert
09/18/2023CABABuy Now
Cabaletta Bio
$1.692207.69%
Derek Archila59%
$14 → $39MaintainsOverweightGet Alert
09/15/2023APLSBuy Now
Apellis Pharmaceuticals
$24.41162.19%
Derek Archila59%
$34 → $64UpgradeEqual-Weight → OverweightGet Alert
09/06/2023ASNDBuy Now
Ascendis Pharma
$164.65-18.62%
Derek Archila59%
$139 → $134MaintainsOverweightGet Alert
08/22/2023CLDXBuy Now
Celldex Therapeutics
$19.895.58%
Derek Archila59%
→ $21Initiates → UnderweightGet Alert
08/11/2023KZRBuy Now
Kezar Life Sciences
$5.76—
Derek Archila59%
—DowngradeOverweight → Equal-WeightGet Alert
08/10/2023ZNTLBuy Now
Zentalis Pharma
$1.792693.3%
Derek Archila59%
$51 → $50MaintainsOverweightGet Alert
07/31/2023BPMCBuy Now
Blueprint Medicines
$89.59—
Derek Archila59%
$55 → $83UpgradeEqual-Weight → OverweightGet Alert
07/28/2023ARGXBuy Now
argenx
$610.00-0.16%
Derek Archila59%
$606 → $609MaintainsOverweightGet Alert
07/24/2023IMVTBuy Now
Immunovant
$19.9965.08%
Derek Archila59%
$27 → $33MaintainsOverweightGet Alert
07/20/2023APLSBuy Now
Apellis Pharmaceuticals
$24.41117.12%
Derek Archila59%
$76 → $53MaintainsEqual-WeightGet Alert
06/20/2023DICEBuy Now
DICE Therapeutics
——
Derek Archila59%
$38 → $48MaintainsEqual-WeightGet Alert
06/16/2023MORBuy Now
MorphoSys
——
Derek Archila59%
→ $17Initiates → OverweightGet Alert
06/14/2023BPMCBuy Now
Blueprint Medicines
$89.59-38.61%
Derek Archila59%
$48 → $55MaintainsEqual-WeightGet Alert
05/24/2023DICEBuy Now
DICE Therapeutics
——
Derek Archila59%
→ $38Initiates → Equal-WeightGet Alert
05/23/2023BPMCBuy Now
Blueprint Medicines
$89.59-46.42%
Derek Archila59%
$47 → $48MaintainsEqual-WeightGet Alert
05/12/2023KZRBuy Now
Kezar Life Sciences
$5.76125.69%
Derek Archila59%
$140 → $130MaintainsOverweightGet Alert
05/05/2023APLSBuy Now
Apellis Pharmaceuticals
$24.41211.35%
Derek Archila59%
$55 → $76MaintainsEqual-WeightGet Alert
04/25/2023MORFBuy Now
Morphic Holding
——
Derek Archila59%
$67 → $80MaintainsOverweightGet Alert
03/21/2023ZYMEBuy Now
Zymeworks
$12.34-2.76%
Derek Archila59%
→ $12Assumes → OverweightGet Alert
03/21/2023VTYXBuy Now
Ventyx Biosciences
$1.375520.44%
Derek Archila59%
→ $77Initiates → OverweightGet Alert
03/09/2023EXELBuy Now
Exelixis
$36.36-36.74%
Derek Archila59%
→ $23Initiates → OverweightGet Alert
01/03/2023KYMRBuy Now
Kymera Therapeutics
$34.0323.42%
Derek Archila59%
$40 → $42MaintainsOverweightGet Alert
01/03/2023KZRBuy Now
Kezar Life Sciences
$5.76143.06%
Derek Archila59%
$170 → $140MaintainsOverweightGet Alert
01/03/2023INCYBuy Now
Incyte
$60.0025%
Derek Archila59%
$72 → $75MaintainsEqual-WeightGet Alert
01/03/2023CABABuy Now
Cabaletta Bio
$1.69728.4%
Derek Archila59%
$4 → $14MaintainsOverweightGet Alert
01/03/2023CCCCBuy Now
C4 Therapeutics
$2.10328.57%
Derek Archila59%
$11 → $9MaintainsEqual-WeightGet Alert
01/03/2023ASNDBuy Now
Ascendis Pharma
$164.657.5%
Derek Archila59%
$169 → $177MaintainsOverweightGet Alert
01/03/2023APLSBuy Now
Apellis Pharmaceuticals
$24.41137.61%
Derek Archila59%
→ $58DowngradeOverweight → Equal-WeightGet Alert
01/03/2023ARVNBuy Now
Arvinas
$8.36485.97%
Derek Archila59%
$83 → $49DowngradeOverweight → Equal-WeightGet Alert
01/03/2023GLUEBuy Now
Monte Rosa Therapeutics
$6.67184.86%
Derek Archila59%
→ $19UpgradeEqual-Weight → OverweightGet Alert
01/03/2023BPMCBuy Now
Blueprint Medicines
$89.59-54.24%
Derek Archila59%
→ $41UpgradeUnderweight → Equal-WeightGet Alert
01/03/2023IMVTBuy Now
Immunovant
$19.9935.07%
Derek Archila59%
$10 → $27UpgradeEqual-Weight → OverweightGet Alert
12/13/2022HZNPBuy Now
Horizon Therapeutics
——
Derek Archila59%
$118 → $116.5DowngradeOverweight → Equal-WeightGet Alert
11/08/2022MORFBuy Now
Morphic Holding
——
Derek Archila59%
$77 → $78MaintainsOverweightGet Alert
11/08/2022KYMRBuy Now
Kymera Therapeutics
$34.035.79%
Derek Archila59%
$35 → $36MaintainsOverweightGet Alert
11/08/2022IMVTBuy Now
Immunovant
$19.99-49.97%
Derek Archila59%
$7 → $10MaintainsEqual-WeightGet Alert
11/08/2022CCCCBuy Now
C4 Therapeutics
$2.10423.81%
Derek Archila59%
$12 → $11MaintainsEqual-WeightGet Alert
11/07/2022ASNDBuy Now
Ascendis Pharma
$164.652.64%
Derek Archila59%
$172 → $169MaintainsOverweightGet Alert
10/18/2022ARGXBuy Now
argenx
$610.00-23.11%
Derek Archila59%
$461 → $469MaintainsOverweightGet Alert
10/18/2022INCYBuy Now
Incyte
$60.0025%
Derek Archila59%
$76 → $75MaintainsEqual-WeightGet Alert
09/22/2022ASNDBuy Now
Ascendis Pharma
$164.654.46%
Derek Archila59%
$167 → $172MaintainsOverweightGet Alert
09/14/2022CABABuy Now
Cabaletta Bio
$1.69136.69%
Derek Archila59%
$14 → $4MaintainsOverweightGet Alert
08/29/2022RXDXBuy Now
Prometheus Biosciences
——
Derek Archila59%
$51 → $71MaintainsOverweightGet Alert
08/17/2022BPMCBuy Now
Blueprint Medicines
$89.59-54.24%
Derek Archila59%
$40 → $41MaintainsUnderweightGet Alert
08/04/2022MORFBuy Now
Morphic Holding
——
Derek Archila59%
$79 → $77MaintainsOverweightGet Alert
07/28/2022INCYBuy Now
Incyte
$60.0026.67%
Derek Archila59%
→ $76Initiates → Equal-WeightGet Alert
06/28/2022KZRBuy Now
Kezar Life Sciences
$5.76195.14%
Derek Archila59%
$130 → $170MaintainsOverweightGet Alert
06/27/2022BPMCBuy Now
Blueprint Medicines
$89.59-55.35%
Derek Archila59%
→ $40Initiates → UnderweightGet Alert
06/01/2022KYMRBuy Now
Kymera Therapeutics
$34.032.85%
Derek Archila59%
$62 → $35MaintainsOverweightGet Alert
05/31/2022NRIXBuy Now
Nurix Therapeutics
$13.6683.02%
Derek Archila59%
→ $25UpgradeEqual-Weight → OverweightGet Alert
05/13/2022RXDXBuy Now
Prometheus Biosciences
——
Derek Archila59%
$53 → $51MaintainsOverweightGet Alert
05/13/2022KZRBuy Now
Kezar Life Sciences
$5.76125.69%
Derek Archila59%
$140 → $130MaintainsOverweightGet Alert
05/12/2022ASNDBuy Now
Ascendis Pharma
$164.656.89%
Derek Archila59%
$190 → $176MaintainsOverweightGet Alert
05/05/2022MORFBuy Now
Morphic Holding
——
Derek Archila59%
$81 → $79MaintainsOverweightGet Alert
05/04/2022KZRBuy Now
Kezar Life Sciences
$5.76143.06%
Derek Archila59%
$190 → $140MaintainsOverweightGet Alert
04/11/2022NRIXBuy Now
Nurix Therapeutics
$13.6683.02%
Derek Archila59%
$28 → $25MaintainsEqual-WeightGet Alert
04/06/2022ZNTLBuy Now
Zentalis Pharma
$1.793643.02%
Derek Archila59%
→ $67Initiates → OverweightGet Alert
03/10/2022RXDXBuy Now
Prometheus Biosciences
——
Derek Archila59%
$42 → $53MaintainsOverweightGet Alert
03/03/2022ASNDBuy Now
Ascendis Pharma
$164.653.25%
Derek Archila59%
$176 → $170MaintainsOverweightGet Alert
02/10/2022KYMRBuy Now
Kymera Therapeutics
$34.0382.19%
Derek Archila59%
→ $62Initiates → OverweightGet Alert
02/10/2022NRIXBuy Now
Nurix Therapeutics
$13.66104.98%
Derek Archila59%
→ $28Initiates → Equal-WeightGet Alert
02/10/2022ARVNBuy Now
Arvinas
$8.361071.94%
Derek Archila59%
→ $98Initiates → OverweightGet Alert
02/10/2022GLUEBuy Now
Monte Rosa Therapeutics
$6.67184.86%
Derek Archila59%
→ $19Initiates → Equal-WeightGet Alert
02/10/2022CCCCBuy Now
C4 Therapeutics
$2.101090.48%
Derek Archila59%
→ $25Initiates → Equal-WeightGet Alert
12/20/2021ARGXBuy Now
argenx
$610.00-35.25%
Derek Archila59%
$390 → $395MaintainsOverweightGet Alert
12/08/2021ARNABuy Now
Arena Pharmaceuticals
——
Derek Archila59%
→ $71Initiates → OverweightGet Alert
12/08/2021RYTMBuy Now
Rhythm Pharmaceuticals
$52.29-42.63%
Derek Archila59%
→ $30Initiates → OverweightGet Alert
12/08/2021RXDXBuy Now
Prometheus Biosciences
——
Derek Archila59%
→ $42Initiates → OverweightGet Alert
12/08/2021IMVTBuy Now
Immunovant
$19.99-54.98%
Derek Archila59%
→ $9Initiates → Equal-WeightGet Alert
12/08/2021APLSBuy Now
Apellis Pharmaceuticals
$24.41244.12%
Derek Archila59%
→ $84Initiates → OverweightGet Alert
12/08/2021ARGXBuy Now
argenx
$610.00-36.07%
Derek Archila59%
→ $390Initiates → OverweightGet Alert
12/08/2021ASNDBuy Now
Ascendis Pharma
$164.656.89%
Derek Archila59%
→ $176Initiates → OverweightGet Alert
12/08/2021CABABuy Now
Cabaletta Bio
$1.69905.92%
Derek Archila59%
→ $17Initiates → OverweightGet Alert
12/08/2021HZNPBuy Now
Horizon Therapeutics
——
Derek Archila59%
→ $137Initiates → OverweightGet Alert
12/08/2021KZRBuy Now
Kezar Life Sciences
$5.76229.86%
Derek Archila59%
→ $190Initiates → OverweightGet Alert
12/08/2021MORFBuy Now
Morphic Holding
——
Derek Archila59%
→ $81Initiates → OverweightGet Alert
06/01/2021IMVTBuy Now
Immunovant
$19.99-54.98%
Derek Archila59%
$28 → $9DowngradeBuy → HoldGet Alert
05/05/2021ESPRBuy Now
Esperion Therapeutics
$1.581165.82%
Derek Archila59%
$37 → $20DowngradeBuy → HoldGet Alert
04/06/2021RXDXBuy Now
Prometheus Biosciences
——
Derek Archila59%
→ $25Initiates → BuyGet Alert
03/11/2021LUMOBuy Now
Lumos Pharma
——
Derek Archila59%
$4 → $24UpgradeHold → BuyGet Alert
02/02/2021IMVTBuy Now
Immunovant
$19.9965.08%
Derek Archila59%
$54 → $33MaintainsBuyGet Alert
10/08/2020IMVTBuy Now
Immunovant
$19.99130.12%
Derek Archila59%
→ $46Initiates → BuyGet Alert
09/01/2020APLSBuy Now
Apellis Pharmaceuticals
$24.4163.87%
Derek Archila59%
→ $40Initiates → BuyGet Alert
08/20/2020MNTABuy Now
Momenta Pharmaceuticals
——
Derek Archila59%
$47 → $52.5DowngradeBuy → HoldGet Alert
08/20/2020PRNBBuy Now
Principia Biopharma
——
Derek Archila59%
$104 → $100DowngradeBuy → HoldGet Alert
08/06/2020ARNABuy Now
Arena Pharmaceuticals
——
Derek Archila59%
$60 → $78MaintainsOverweightGet Alert
08/04/2020IVABuy Now
Inventiva
$2.97506.06%
Derek Archila59%
→ $18Initiates → BuyGet Alert
07/23/2020GNFTBuy Now
Genfit
$3.62—
Derek Archila59%
—UpgradeHold → BuyGet Alert
07/10/2020GLPGBuy Now
Galapagos
$25.84646.9%
Derek Archila59%
$298 → $193DowngradeBuy → HoldGet Alert
06/09/2020VIEBuy Now
Viela Bio
——
Derek Archila59%
→ $58Initiates → HoldGet Alert
05/12/2020CBAYBuy Now
CymaBay Therapeutics
——
Derek Archila59%
$4 → $8UpgradeHold → BuyGet Alert
04/15/2020OKEBuy Now
ONEOK
$98.01-58.17%
Derek Archila59%
$61 → $41Reiterates → BuyGet Alert
03/31/2020AMRNBuy Now
Amarin Corp
$0.431760.47%
Derek Archila59%
$24 → $8MaintainsHoldGet Alert
03/19/2020NGMBuy Now
NGM Biopharmaceuticals
——
Derek Archila59%
$33 → $32MaintainsBuyGet Alert
03/17/2020DBVTBuy Now
DBV Technologies
$5.0119.76%
Derek Archila59%
$180 → $60DowngradeBuy → HoldGet Alert
03/11/2020PRNBBuy Now
Principia Biopharma
——
Derek Archila59%
$66 → $76MaintainsBuyGet Alert
02/25/2020NGMBuy Now
NGM Biopharmaceuticals
——
Derek Archila59%
$26 → $33MaintainsBuyGet Alert
01/28/2020MNTABuy Now
Momenta Pharmaceuticals
——
Derek Archila59%
$29 → $43MaintainsBuyGet Alert
01/09/2020DBVTBuy Now
DBV Technologies
$5.01259.28%
Derek Archila59%
$100 → $180UpgradeHold → BuyGet Alert
12/19/2019PRNBBuy Now
Principia Biopharma
——
Derek Archila59%
$51 → $66MaintainsBuyGet Alert
12/16/2019AMRNBuy Now
Amarin Corp
$0.435946.51%
Derek Archila59%
$28 → $26DowngradeBuy → HoldGet Alert
11/25/2019CBAYBuy Now
CymaBay Therapeutics
——
Derek Archila59%
—DowngradeBuy → HoldGet Alert
09/18/2019ESPRBuy Now
Esperion Therapeutics
$1.584330.38%
Derek Archila59%
$112 → $70MaintainsBuyGet Alert
06/25/2019NGMBuy Now
NGM Biopharmaceuticals
——
Derek Archila59%
→ $26Initiates → BuyGet Alert
06/25/2019CBAYBuy Now
CymaBay Therapeutics
——
Derek Archila59%
→ $14Initiates → BuyGet Alert
04/17/2019PRNBBuy Now
Principia Biopharma
——
Derek Archila59%
→ $45Initiates → BuyGet Alert
03/22/2019AMRNBuy Now
Amarin Corp
$0.436179.07%
Derek Archila59%
→ $27Initiates → BuyGet Alert
12/11/2018VNDABuy Now
Vanda Pharma
$5.12466.41%
Derek Archila59%
→ $29DowngradeOutperform → PerformGet Alert
09/21/2018VNDABuy Now
Vanda Pharma
$5.12466.41%
Derek Archila59%
$27 → $29MaintainsOutperformGet Alert
09/14/2018DBVTBuy Now
DBV Technologies
$5.01598.6%
Derek Archila59%
→ $350Initiates → BuyGet Alert
07/16/2018KZRBuy Now
Kezar Life Sciences
$5.76420.83%
Derek Archila59%
→ $300Initiates → OutperformGet Alert
06/22/2018HRTXBuy Now
Heron Therapeutics
$2.491908.03%
Derek Archila59%
$34 → $50MaintainsOutperformGet Alert
01/03/2018ARNABuy Now
Arena Pharmaceuticals
——
Derek Archila59%
—UpgradeMarket Perform → OutperformGet Alert
11/22/2017MNKBuy Now
Mallinckrodt
——
Derek Archila59%
—DowngradeOutperform → PerformGet Alert
11/15/2017URGNBuy Now
UroGen Pharma
$11.53342.32%
Derek Archila59%
$32 → $51MaintainsOutperformGet Alert
10/31/2017HRTXBuy Now
Heron Therapeutics
$2.49984.34%
Derek Archila59%
→ $27Initiates → OutperformGet Alert
10/30/2017VNDABuy Now
Vanda Pharma
$5.12407.81%
Derek Archila59%
$21 → $26MaintainsOutperformGet Alert
09/07/2017PRGOBuy Now
Perrigo
$27.85215.98%
Derek Archila59%
→ $88Initiates → OutperformGet Alert
09/07/2017PCRXBuy Now
Pacira BioSciences
$23.67—
Derek Archila59%
—Initiates → Market PerformGet Alert
08/15/2017ZYNEBuy Now
Zynerba Pharmaceuticals
——
Derek Archila59%
—DowngradeOutperform → Market PerformGet Alert
08/03/2017TEVABuy Now
Teva Pharmaceutical Indus
$16.71—
Derek Archila59%
—DowngradeOutperform → PerformGet Alert
04/12/2017VNDABuy Now
Vanda Pharma
$5.12—
Derek Archila59%
—Initiates → OutperformGet Alert
09/02/2016TEVABuy Now
Teva Pharmaceutical Indus
$16.71—
Derek Archila59%
—UpgradePerform → OutperformGet Alert
02/25/2016ESPRBuy Now
Esperion Therapeutics
$1.583950.63%
Derek Archila59%
$105 → $64MaintainsBuyGet Alert
11/12/2015ZYNEBuy Now
Zynerba Pharmaceuticals
——
Derek Archila59%
$40 → $34MaintainsOutperformGet Alert
05/08/2015ESPRBuy Now
Esperion Therapeutics
$1.587241.77%
Derek Archila59%
$106 → $116MaintainsBuyGet Alert
05/08/2015ESPRBuy Now
Esperion Therapeutics
$1.587241.77%
Derek Archila59%
$106 → $116MaintainsBuyGet Alert
05/08/2015CBAYBuy Now
CymaBay Therapeutics
——
Derek Archila59%
$15 → $19MaintainsBuyGet Alert
03/06/2015MNKBuy Now
Mallinckrodt
——
Derek Archila59%
$122 → $140MaintainsOutperformGet Alert
02/23/2015ASNDBuy Now
Ascendis Pharma
$164.65—
Derek Archila59%
—Initiates → OutperformGet Alert
02/17/2015ESPRBuy Now
Esperion Therapeutics
$1.585596.2%
Derek Archila59%
$60 → $90MaintainsBuyGet Alert
01/20/2015CBAYBuy Now
CymaBay Therapeutics
——
Derek Archila59%
$10 → $15MaintainsBuyGet Alert
09/17/2014CBAYBuy Now
CymaBay Therapeutics
——
Derek Archila59%
→ $10Initiates → BuyGet Alert
07/16/2014MNKBuy Now
Mallinckrodt
——
Derek Archila59%
→ $100Initiates → OutperformGet Alert
07/22/2013ESPRBuy Now
Esperion Therapeutics
$1.581418.99%
Derek Archila59%
→ $24Initiates → BuyGet Alert